Posts in tag

Gene


~ Preclinical data show the utility of Gennao’s proprietary first-in-class monoclonal antibody 3E10-D31N (GMABD31N), a cell penetrating antibody, to non-covalently bind to and systemically deliver therapeutic levels of multiple types of nucleic acid payloads to cells in vitro and tumors in vivo ~ ~ GMABD31N combined with a RIG-I ligand 3pRNA (GMABD31N/3pRNA) efficiently targets and …

DUBLIN, Ireland–(BUSINESS WIRE)–ERS Genomics Limited, which was formed to provide broad access to foundational CRISPR/Cas9 intellectual property today announced the signing of a license agreement with Otsuka Pharmaceutical Co. Ltd. (Otsuka). The license grants Otsuka access to CRISPR/Cas9 genome editing technology for its internal research and development initiatives to address areas of unmet medical need. …

Multiple sclerosis (MS) is the most common neurological disease in young adults, affecting more than 2 million individuals worldwide, with about 1500 cases in Estonia. About 20% of MS patients experience optic neuritis (ON) as the presenting symptom, but not all ON patients develop MS. The TalTech gene technology research unit, in collaboration with the …

Might a new technological development of researchers from Tel Aviv University soon revolutionize the dairy products we consume? The initiators of the development believe that in the not-too-distant future we will be able to buy dairy products in the supermarket that are identical in taste and color to the ordinary dairy products that we consume …

The new agreement will provide Lonza with access to Arbor’s gene editing technology Quote from David Cheng, CEO of Arbor: “Arbor’s differentiated gene editing technologies allow Lonza to manufacture the next generation of therapeutics. Arbor is committed to seeking and working with partners in this field to build an ecosystem for the research, development and …

A “nanoPCR” technology was developed for the point-of-care (POC) diagnosis of coronavirus disease-19 (COVID-19). This new technology can diagnose the infection within ~20 minutes while retaining the accuracy of conventional reverse transcription polymerase chain reaction (RT-PCR) technology. A team of researchers led by Professor CHEON Jinwoo, the director of the Center for Nanomedicine (CNM) within …

New York, Nov. 19, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Gene Amplification Technologies Industry” – https://www.reportlinker.com/p05817590/?utm_source=GNW 7% in the year 2020 and thereafter continue to grow to reach US$6.8 billion by the year 2027, trailing a post COVID-19 CAGR of 11.4% over the analysis period 2020 through 2027. Gene …

PARIS and SAN FRANCISCO, Oct. 30, 2020 /PRNewswire/ — Recombia Biosciences announces the launch of operations in Brisbane, California. The company aims to harness its proprietary genome editing technologies to accelerate the development of yeast for sustainable production of fermented ingredients. For the next few years Recombia and Lesaffre will be joining forces in the …

CLOSE Scientists Emmanuelle Charpentier and Jennifer Doudna have won the Nobel Prize in chemistry for their pioneering work on the gene-editing tool CRISPR. The tool has been used to engineer better crops and to try to cure human diseases. (Oct. 7) AP Domestic Coronavirus tests performed in labs are the gold standard for accuracy, and antigen …

Reviewed by Emily Henderson, B.Sc.Oct 22 2020 Genome editing of human embryos represents one of the most contentious potential scientific applications today. But what if geneticists could sidestep the controversy by editing sperm and eggs instead? According to a new paper co-written by a University of Illinois at Urbana-Champaign legal expert who studies the ethical …